MedPath

Effectiveness of Guanxinning Tablet on the Stable Coronary Artery Disease based on the Real World: A Multi-center Registration Study

Phase 4
Not yet recruiting
Conditions
stable Coronary Heart Disease
Registration Number
ITMCTR1900025340
Lead Sponsor
Xiyuan Hospital, CACMS
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) Patients with stable coronary artery disease with definitive diagnosis
(2) Voluntary participation in this research

Exclusion Criteria

Other conditions considered unsuitable for participation in this research by the researchers.

Study & Design

Study Type
Observational study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.